MIFH
VCYT icon

Migdal Insurance & Financial Holdings’s Veracyte VCYT Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,131
Closed -$652K – 675
2021
Q1 		$652K Buy
12,131
+7,544
+164% +$435K 0.01% 292
2020
Q4 		$224K Buy
+4,587
New +$213K ﹤0.01% 304

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Migdal Insurance & Financial Holdings's VCYT Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 12,131 shares — an estimated $652K sold.

Migdal Insurance & Financial Holdings first reported a position in VCYT in Q4 2020 and held it in 2 quarters. The position peaked at $652K in Q1 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 12,131 Veracyte shares in Q2 2021, an estimated $652K.
  • Migdal Insurance & Financial Holdings first reported a position in Veracyte in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Veracyte position peaked at $652K in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.